INTRODUCTION
Prostate cancer (PCa) is the second leading cause of cancerrelated death among men in Western society. 1, 2 Geographical differences in incidence rates suggest that environmental factors play a significant role in the progression and development of PCa. As diet varies significantly across nationalities and is an easily modified, low-cost intervention, many prior studies have queried dietary contributions to PCa development and outcome. Consumption of high amounts of dietary fat is a commonly identified factor in the development and progression of PCa. [3] [4] [5] [6] Indeed, per capita total fat consumption is strongly correlated with national PCa mortality in some data sets. 7 In contrast, the multicenter European Prospective Investigation into Cancer and Nutrition (EPIC) study, which enrolled 142 520 men, found no association between dietary fat intake and PCa risk. 8 When specific types of fat are examined, population-based studies suggest that consumption of fatty fish reduces PCa incidence. 9, 10 Similarly, the 12-year prospective Health Professionals Follow-Up Study showed that higher consumption of fish was strongly associated with a reduced risk of metastatic PCa. 11 Olive oil has also been touted as potentially decreasing PCa risk. Indeed, a randomized trial showed that a Mediterranean diet (high in both o-3 fatty acids and olive oil-derived fats) may protect against many forms of cancer, including prostate. 12 On the contrary, other studies have suggested that increased consumption of o-6 fatty acids 13 and animal fats (saturated fat) 14 can increase the risk of PCa.
Similarly, in vivo animal studies have suggested that increased dietary fat promotes PCa growth. [15] [16] [17] However, the vast majority of these studies have focused on the amount of dietary fat and neglected to examine the type of fat consumed. Of major dietary fat sources, fish oil is the most heavily studied source. Previous mouse xenograft studies have suggested that diets high in fish oil (an o-3 fatty acid), relative to diets with a greater proportion of corn oil (an o-6 fatty acid), may slow tumor growth and prolong survival. 18, 19 Prior studies by our group have suggested that decreasing dietary saturated fat levels (animal fats, such as milk fat and lard) do not prolong survival in either intact or castrated mouse PCa xenograft models. 20, 21 However, to our knowledge, never before has a head-to-head trial of the effect of multiple types of dietary fat on tumor progression and PCa survival been undertaken. As such, we sought to systematically examine this question and perhaps identify mechanisms by which more 'prostate-healthy' fats exert their effects. We hypothesized that fish oil-and olive oil-based diets would slow tumor progression relative to the 'less healthy' corn oil-and animal fat-based diets.
MATERIALS AND METHODS
Cell culture LAPC-4 human PCa cells were a generous gift from William J Aronson, University of California (UCLA) School of Medicine. This cell line was developed at UCLA by direct transfer of cancer cells from a patient with advanced prostatic adenocarcinoma. LAPC-4 produces PSA, has a wildtype androgen receptor and shows features of hormone-dependent growth and metastasis. 22 This cell line has been frequently used to model localized androgen-sensitive disease. [23] [24] [25] We specifically chose this cell line for its hormone dependence, as we aim to model the effect of dietary intervention on early-stage disease, which is typically androgen sensitive. Cells were maintained in Iscove's modified medium with 10% fetal bovine serum and supplemented with the synthetic androgen R1881 at 1 nM. Cells were grown in 5% CO 2 at 37 1C and harvested by trypsinization at B80% confluence in log-phase growth.
Animal studies
After approval from the Duke University Institutional Animal Care and Use Committee, 96 male severe combined immunodeficient (SCID) (CB.17 scid/ scid) mice, aged 8 weeks, were purchased from Taconic Farms (Hudson, NY, USA). Animals were housed five to a cage and fed an ad libitum diet of standard mouse chow (20% protein, 9% fat and 71% carbohydrate kilocalories) for a 1-week acclimation period. Following acclimation, mice were injected in the flank with 1 Â 10 5 LAPC-4 cells in 0.1 ml of Matrigel (Becton Dickinson, Franklin Lakes, NJ, USA) and returned to group housing with ad libitum feeding using standard mouse chow. Eleven days after injection, mice were transitioned to single housing. Given the importance of energy balance in modulating tumor growth, all mice were housed one per cage for the duration of the study to permit precise measurement of caloric intake. 26 Given that changes in housing can be stressful, we waited 3 additional days before randomizing the mice to the four-diet arms at 2 weeks after injection. We elected to randomize the mice at 2 weeks following injection to ensure that we were studying the effect of diet on PCa progression rather than disease initiation. By 14 days after injection, all tumor xenografts were likely to have taken and become metabolically active, allowing us to model treatment of early stage disease.
Mice were randomized to one of four diets (all 16% protein, 35% fat, 49% carbohydrate kilocalories), which differed only in their dietary fat source. Fat sources were fish oil, olive oil, corn oil and animal fat (lard/milk fat). The diets were prepared by TestDiet (Indianapolis, IN, USA) ( Table 1) . Primary fatty acid compositions were 30-40% o-3 for fish oil, 65-80% oleic acid for olive oil, 54% o-6 for corn oil and 56% saturated fat for the animal fat ( Table 2 ). In a pilot study (data not shown), we determined that fish oilfed mice consumed fewer calories on average than the other groups. As such, the fish oil group was fed ad libitum, and mice in the other groups were fed via a modified pair-feeding protocol to maintain isocaloric intake between the groups. 20 Mice were weighed twice weekly to ensure equal body weights across groups.
When tumors became palpable, their dimensions were measured using digital caliper. Tumor volumes, measured twice weekly, were calculated using the following formula: width Â height Â length Â 0.5236. 27 At 3 weeks after randomization to the diets (5 weeks posttumor injection), mice were bled via the facial vein, and blood glucose was measured using a handheld Accu-Chek Active glucometer (Roche Diagnostics, Indianapolis, IN, USA). Glucose measurements were taken immediately prior to feeding, which likely reflected a partially fasted state, as the majority of the animals consumed all of their prescribed diet prior to food allocation each day. However, we did not remove the diet from the animals' cages at any given time before assessing glucose levels, so we cannot comment on how long the animals were fasted prior assessment.
Animals were euthanized using a lethal dose of pentobarbital when tumor volumes reached 1000 mm 3 or when the health of the animal appeared compromised per institutional criteria (ruffled fur, hunched posture, lethargy, weight loss, etc.). Serum was obtained via cardiac puncture. All tumor tissue was surgically excised from the subcutaneous flank pockets in which it was growing. Serum and tumor samples were snap frozen at À 80 1C for subsequent analysis.
Serum from eight median-surviving mice from each group (total 32 mice) was assayed for levels of murine insulin, insulin-like growth factor (IGF)-1, IGF-1-binding protein-3 (IGFBP-3) and prostaglandin E-2 (PGE-2) using mouse-specific enzyme-linked immunosorbent assays (Linco, Billerica, MA, USA; R&D Systems, Minneapolis, MN, USA; and Neogen, Lexington, KY, USA, respectively). Serum was also assessed for human PSA produced by the LAPC-4 xenograft using enzyme-linked immunosorbent assay (Abazyme, Needham, MA, USA).
Western blot analysis was conducted on the xenograft tumor tissue of six median-surviving mice from each group (total 24 mice). Tissue lysate was first prepared using the QProteome Mammalian Protein Preparation kit (Qiagen, Valencia, CA, USA). A total of 1 ml cell lysis buffer was added to 50-60 mg of prostate xenograft tumor tissue and processed using a mechanical tissue homogenizer. Homogenates were centrifuged at 10 000 r.p.m. for 20 min to clarify the lysates, and total protein concentration was determined using the BCA Protein Assay Reagent (Thermo Fisher Scientific, Rockford, IL, USA). All lysates were stored at À 80 1C until further analysis.
To conduct the western blot analysis, denatured samples of tissue homogenates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and subsequent immunoblotting using the Fast Western Blot kit (Pierce-Thermo Scientific, Rockford, IL, USA) to determine expression of target proteins. The primary antibody used for immunoblotting was anti-cyclooxygenase-2 (COX-2) (160112) from Cayman Chemical (Ann Arbor, MI, USA). Given the need to run 24 samples and given that the gels hold 12 samples, we ran samples of three mice per group from four groups on each gel, requiring a total of two gels to be analyzed. These experiments were repeated twice. Densitometric analysis was performed using the ImageJ software (National Institutes of Health, Bethesda, MD, USA).
RNA isolation and microarray analysis
Total RNA from the excised xenograft tumors of each of the six mediansurviving mice per group was purified with TriZol (Invitrogen, Grand Island, NY, USA) and verified to be intact by Bioanalyzer. Extracted RNA was then hybridized to Affymetrix Human genome 133A 2.0 arrays (Affymetrix, Santa Clara, CA, USA) using a standard protocol described previously. 28 All data have been deposited into .cel files (GEO (GSE40654)).
Statistical analysis
The primary end point was survival, defined as time from randomization to death, which was examined using the log-rank test. Graphically, survival was represented using Kaplan-Meier curves. Comparisons of secondary outcomes including body weight, tumor volume, serum levels of PSA, IGF Type of fat varies by diet. All diets were formulated with a single fat source, with no contamination by other sources of fat. axis hormones, glucose and PGE-2 were made, and tumor COX-2 levels were determined using the Kruskal-Wallis test.
For microarray analyses, all .cel files were normalized by the robust multi-average method (Expression Console, Affymetrix). Given the distinct biological response of the fish oil, we compared differences in biological pathways between the six median-surviving fish oil-fed mice and the six median-surviving mice from each of the other dietary groups combined (18 samples total). Data were analyzed with gene set enrichment analysis using the Broad public server to identify biological pathways affected by dietary fat source. 29 All statistical analyses were performed using STATA 10.0 (Stata, College Station, TX, USA), with Pp0.05 considered statistically significant.
RESULTS

Body weight
At randomization, mouse weights were equivalent across arms (P ¼ 0.99). A pair-feeding protocol allowed for isocaloric feeding between groups. Despite careful titration of caloric intake, mouse body weights differed significantly across groups at a small number of time points (Figure 1 ). Of note, during the first 20 days, fish oil-fed mice were slightly lighter than the other groups (typically o1 g difference in body weight), with no appreciable differences during the next 20 days. By day 40, fish oil-fed mice were the heaviest and remained so for the majority of subsequent time points until only a few mice were still alive, near day 95. Overall, all mice consumed their prescribed diets without observed toxicity in any group.
Tumor growth and survival Median tumor volumes at randomization (day 14) were equivalent across all four groups (P ¼ 0.99; Figure 2 ). As the study progressed, disparities in tumor growth became apparent. From approximately day 28 (14 days after randomization), fish oil-fed mice demonstrated significantly smaller tumors than mice in each of the other dietary groups. This trend continued throughout the duration of the study. Although fish oil-fed mice had smaller tumors at every time point, these differences reached statistical significance only at certain, but not all, time points. Of the 96 mice included in the study, 11 (12%) were required to be killed prior to their tumor volumes reaching 1000 mm 3 due to apparent compromise in overall health. Of these mice, two were from the corn oil group, three from fish oil, three from olive oil and three from the animal fat group. Overall, there were trends toward an association between diet and survival, although this did not reach statistical significance (P ¼ 0.093, log-rank test; Figure 3 ). When examined in two-way analyses, mice in the fish oil group survived longer than mice in any other group (P ¼ 0.014 for fish vs corn, P ¼ 0.017 for fish vs olive, P ¼ 0.090 for fish vs animal fat). After combining the three non-fish oil groups, all of which had similar survival times, fish oil was associated with a significant improvement in survival vs nonfish oil diets (P ¼ 0.014, log-rank test; Figure 4 ).
Serum and tissue analyses
Serum glucose at the time of death differed significantly among groups, with the fish oil group having the highest levels (P ¼ 0.03; Supplementary Figure 1 ). Median serum PSA at death was 38.7 ng ml À 1 (interquartile range: 33.1-64.2), 44.0 ng ml À 1 (34.6-48.4), 59.6 ng ml À 1 (43.6-78.5) and 53.0 ng ml À 1 (41.0-73.8) for the corn, fish, olive and animal fat groups, respectively; these values did not differ significantly (P ¼ 0.24). Similarly, we saw no significant difference in serum IGF axis parameters among groups (insulin P ¼ 0.28, IGF-1 P ¼ 0.18, IGFBP-3 P ¼ 0.18, IGF-1/IGFBP-3 ratio P ¼ 0.33; Figure 5 ). Serum PGE-2 levels were also similar (P ¼ 0.40), and there was no significant difference in tumor COX-2 expression across dietary groups (P ¼ 0.31).
Gene expression profiles and gene set enrichment analysis
To understand the mechanisms underlying the slower growth of xenograft tumors in mice consuming the fish oil diet, we performed global gene expression analysis using Affymetrix U133 A2 arrays to analyze six xenograft tumors excised from each of the four treatment groups for a total of 24 samples. The microarray data were normalized by the robust multi-average method, and the differences in the pathway composition between the 6 fish oil and 18 non-fish oil diet samples were compared using gene set enrichment analysis. 29 The gene set enrichment analysis applied a Kolmogorov-Smirnov statistic to determine whether specific biological processes (represented as 4850 gene sets in the Molecular Signature Database (MSigDB) http://www.broadinstitute.org/gsea/msigdb/collections.jsp#C2) were enriched or depleted in tumors of mice taking fish oil (Figure 6a ). This analysis revealed 41 gene sets that were depleted in fish oil samples with a false discovery rate of o25%. No gene set was enriched in the fish oil samples. Among the gene sets most significantly depleted in the fish oil group, two biological processes were particularly prominent: (1) regulation of insulin synthesis and secretion (e.g., gene sets related to reactome insulin synthesis, glucose regulation of insulin secretion and diabetes pathways) ( Figure 6b ) and (2) mitochondrial activity (e.g., gene sets related to the mitochondrial gene module and mitochondrial oxidative phosphorylation) (Figure 6c ).
DISCUSSION
Epidemiologic studies suggest that increased dietary fat consumption has a negative effect on PCa outcomes; however, it is unclear to what extent the type of dietary fat consumed influences disease initiation and progression. Indeed, both populationbased 9-11 and xenograft 18, 19 studies have suggested that fish oil consumption decreases PCa risk. Other studies have shown that, when using a corn oil-based diet, decreasing total dietary fat increases survival in a xenograft model. 16, 17 In contrast, another study demonstrated no improvement in PCa outcome when the amount of dietary fat was decreased using a saturated fat-based diet. 20, 21 This raised the hypothesis that, in addition to the amount of dietary fat being important, the type of fat mattered too. Thus, we sought to systematically examine the effects of various types of fat on PCa progression. We found that male mice xenografted with LAPC-4 tumors fed a diet in which the dietary fat source was fish oil outlived mice fed diets composed of corn oil, olive oil or animal fat; survival was similar across the non-fish oil groups. Gene expression analyses revealed decreased signal related to mitochondrial and insulin synthesis/secretion pathways in the fish oil-fed mice relative to other groups, suggesting that these pathways may be important for mediating the anti-PCa activity of our fish oil-based diet. Numerous but not all population-based studies have demonstrated a correlation between high dietary fat intake and PCa initiation/progression. 7, 8, [30] [31] [32] [33] [34] However, these studies comment only on the amount, not the type, of dietary fat consumed; most of these studies assessed people eating a primarily 'Western' diet high in fats from vegetable oils, meat and dairy sources, all of which are thought to promote PCa development and progression.
Thus, it is noteworthy that other studies have shown both a diet high in cold-water fish [9] [10] [11] and the Mediterranean diet 35 (rich in plant foods, fish and olive oil) to decrease PCa risk. Moreover, a prospective phase II randomized trial of men undergoing radical prostatectomy showed that a low-fat diet with fish oil supplementation reduced tumor Ki67 expression compared with Western diet controls, 36 although promising future studies are required to apply this intervention in a longer-term setting. Although it is difficult to isolate a single dietary component in dietary intervention trials, long-term interventions modifying dietary fat have been undertaken previously and proved to be feasible. 37 Given the challenges of studying dietary effects in humans, studies using animal models offer significant insight into this area. In a mouse xenograft model, high consumption of o-3 fatty acids (the primary fatty component of fish oil) has been shown to impair tumor cell proliferation, increase apoptosis and reduce tumor mass. 18, 19, 38 These findings align with the results of the current study, in which fish oil-fed mice demonstrated prolonged survival relative to mice consuming diets in which the fat source was olive oil, corn oil or animal fat.
The beneficial effects of fish oil are thought to stem from the ability of o-3 fatty acids to suppress the production of arachidonic acid, which, in turn, suppresses the production of arachidonic acid-derived eicosanoids, in particular, prostaglandins and thromboxanes. Prostaglandins produced from arachidonic acid (specifically, PGE-2) tend to be pro-inflammatory and proproliferative in contrast to prostaglandins derived from o-3 fatty acids, which tend to be less favorable for the growth and development of cancer cells. 39 Moreover, incorporation of o-3 fatty acids has been shown to suppress the production of COX-2, which further diminishes the production of pro-inflammatory prostaglandins. 40 In this study, however, we found no significant difference in serum PGE-2 and tumor COX-2 levels across the study groups. This may be due to the relatively small sample size or perhaps argues for an alternative mechanism underlying the positive effect seen with the fish oil diet. Alternatively, using samples at the time of death when all mice have large tumors, we may have missed the window of time wherein there were differences in PGE-2 and/or COX-2. However, in support of the idea that fish oil may alter PCa biology independent of COX-2 and PGE-2, we note a recent preprostatectomy randomized trial that showed that fish oil supplementation lowered tumor Ki67 levels without changes in COX-2 or PGE-2 levels. 36 Therefore, as we noted that prior dietary studies by our group appeared to 'work' via altering IGF/insulin hormone levels, we evaluated the insulin/IGF axis. However, again, no significant differences were noted.
Given the lack of corroborative data to support our two leading hypotheses for why fish oil-fed mice survived the longest, we turned to gene expression analysis. Using this approach, we found significant downregulation of pathways related to insulin synthesis and secretion as well as mitochondrial activity in tumors from mice fed fish oil. Although serum insulin levels were not different between the fish oil arm and other dietary groups, such a comparison may not fully reflect insulin activity within the tumor microenvironment. Thus, although we cannot easily explain how a fish oil diet may have altered the tumor microenvironment to specifically inhibit insulin signaling, the gene expression data are nonetheless hypothesis generating, suggesting the existence of such a difference in insulin signaling between the groups. Indeed, this may have contributed to prolonged survival of the fish oil-fed mice, given that insulin is a potent direct mitogen for PCa. 41, 42 Moreover, a recent study found that insulin increases de novo steroidogenesis, including androgen production, in PCa cells. 43 Notably, cholesterol -the backbone of steroid synthesis -must be imported into the mitochondria for conversion to pregnenolone before steroidogenesis/androgen synthesis can occur. Thus, the results revealed in our gene expression analyses, namely, decreased insulin signaling and decreased mitochondrial activity, appear to fit with these external findings. Ultimately, further studies are needed to better elucidate the exact mechanisms through which a fish oil-based diet slows PCa xenograft growth.
This study must be viewed in light of its limitations. First, as with any single animal model, further studies in other models are needed before any generalizable conclusions can be drawn. More broadly, the use of an animal model is itself a limitation, given that to what degree animal studies model human PCa is unclear and ultimately these results need to be validated in human studies. Second, our study utilized a simplified diet in which all dietary fat was provided by a single source, which is unlikely to be reproduced in humans given the varied and complex nature of human dietary consumption. Moreover, evolving understandings of ethnic variations in bioavailability of dietary fatty acid metabolites must be considered; 44 as such, it is possible that these interventions would require targeting to specific racial/ ethnic groups for maximal efficacy. Third, we observed higher blood glucose in fish oil-fed mice at the time of death. This likely represents a slight overfeeding of fish oil-fed mice relative to other groups, an assessment supported by the observation that mice in the fish oil group were slightly but significantly heavier at time of death than mice in other groups. However, given that increased caloric intake and body mass are generally positively associated with larger and more aggressive PCa tumors, prolonged survival of the fish oil-fed mice in our study actually argues even more strongly for the beneficial effects of this diet. 27, 45, 46 
CONCLUSION
We found that in a mouse PCa xenograft model, mice fed a diet in which fish oil provided the sole source of fat outlived mice fed diets composed of corn oil, olive oil or animal fat; survival was similar across the non-fish oil groups. On gene expression analysis, the fish oil-fed group demonstrated downregulation of pathways related to mitochondrial activity and insulin synthesis/secretion, suggesting the hypothesis that these pathways may be important in producing the benefits of the fish oil diet. The results of our study suggest that increased dietary intake of fish oil may slow PCa progression. Further research is needed to characterize the utility of this potentially low-cost, low-risk intervention in human populations as well as to better understand the potential mechanisms through which this intervention slows PCa progression.
